Cart
sales@molnova.com
KUNG38
CAS No. 1887033-00-2
KUNG38( KUNG-38 | KUNG 38 )
Catalog No. M12953 CAS No. 1887033-00-2
A potent, selective Grp94 inhibitor with Kd of 0.44 uM; displays 19-fold selecticity over Hsp90α.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1143 | Get Quote |
|
| 50MG | 2322 | Get Quote |
|
| 100MG | 3060 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKUNG38
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective Grp94 inhibitor with Kd of 0.44 uM; displays 19-fold selecticity over Hsp90α.
-
DescriptionA potent, selective Grp94 inhibitor with Kd of 0.44 uM; displays 19-fold selecticity over Hsp90α; induces the degradation of integrin α2 in MDA-MB-231 cells.
-
In Vitro——
-
In Vivo——
-
SynonymsKUNG-38 | KUNG 38
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1887033-00-2
-
Formula Weight411.24
-
Molecular FormulaC18H16Cl2N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClC1=CC=C(CN2C=CN=C2CCC3=C(C(OC)=O)C(O)=CC(O)=C3Cl)O1
-
Chemical NameMethyl 3-Chloro-2-(2-(1-((5-chlorofuran-2-yl)methyl)-1H-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Crowley VM, et al. J Med Chem. 2016 Apr 14;59(7):3471-88.
molnova catalog
related products
-
TAS-116
TAS-116 is a novel potent, selective, orally available HSP90α/β inhibitor with Ki of 34.7, 21.3, >50,000, and >50,000 nM for HSP90α, HSP90β, GRP94, and TRAP1, respectively.
-
2',4'-DIHYDROXYCHALC...
2',4'-Dihydroxychalcone as a compound with Hsp90 inhibitory and antifungal effectsIn the presence of 2',4'-DHC (8 g/mL), radial growth of Aspergillus fumigatus was inhibited 20% compared to the control, and green pigmentation was completely blocked.
-
NVP-AUY922
A potent and selective HSP90 inhibitor with IC50 of 21 and 7.8 nM for HSP90β and HSP90α, respectively.
